Literature DB >> 12163681

A diet containing alpha-cellulose and fish oil reduces aberrant crypt foci formation and modulates other possible markers for colon cancer risk in azoxymethane-treated rats.

Leana J Coleman1, Eva K Landström, Peter J Royle, Anthony R Bird, Graeme H McIntosh.   

Abstract

There is a need for better understanding of the roles of dietary fats and fibers in colon cancer risk. We examined the effect of different dietary fiber and fat sources on an azoxymethane (AOM)-induced colon cancer in rats. In a 2 x 3 factorial design, rats were fed a semipurified diet containing soy-derived fiber (Fibrim), alpha-cellulose (Solkafloc) or resistant starch (RS; Hi-maize) at 10 g dietary fiber/100 g diet, combined with fish oil (FO) or sunflower seed oil (SSO) at 10 g/100 g diet, and lard added to all diets at 10 g/100 g, to provide a total of 20 g mixed fat/100 g diet. Sprague-Dawley rats (28 d of age) consumed diets for 4 wk and then two doses of AOM (15 mg/kg body) were administered 1 wk apart by subcutaneous injection. Rats were killed after 13 wk of consuming experimental diets. Colons were fixed in formalin and aberrant crypt foci (ACF) were quantified after staining. ACF counts were higher (+66%, P < 0.01) in rats fed SSO and RS, than in those fed alpha-cellulose and FO. Rats fed FO had 19% fewer ACF than those fed SSO (P < 0.05). alpha-Cellulose was associated with the highest cecal butyrate concentration (P < 0.001), the highest beta-glucuronidase specific activity (P < 0.001) and the lowest cecal water cytotoxicity (P < 0.001) relative to soy fiber- and RS-fed rats. There were inverse correlations between the number of ACF and cecal butyrate concentration (r = -0.33, P < 0.05) and between cecal water cytotoxicity and beta-glucuronidase activity (r = -0.70, P < 0.001). The greatest protection was associated with alpha-cellulose as the fiber source and FO as the fat source as measured by colon ACF numbers in rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163681     DOI: 10.1093/jn/132.8.2312

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

1.  Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.

Authors:  Michael McCulloch; Michael Broffman; Mark van der Laan; Alan Hubbard; Lawrence Kushi; Donald I Abrams; Jin Gao; John M Colford
Journal:  Integr Cancer Ther       Date:  2011-09-30       Impact factor: 3.279

2.  Diets Containing Shiitake Mushroom Reduce Serum Lipids and Serum Lipophilic Antioxidant Capacity in Rats.

Authors:  Shanggong Yu; Xianli Wu; Matthew Ferguson; Rosalia Cm Simmen; Mario A Cleves; Frank A Simmen; Nianbai Fang
Journal:  J Nutr       Date:  2016-10-19       Impact factor: 4.798

3.  Effects of dual modified resistant indica rice starch on azoxymethane-induced incipient colon cancer in mice.

Authors:  Huaibo Yuan; Xiping Zhu; Deyi Chen; Wenjuan Wang; Shaohua Meng; Junhui Wang
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

4.  Interactive effects of dietary resistant starch and fish oil on short-chain fatty acid production and agonist-induced contractility in ileum of young rats.

Authors:  Glen S Patten; Michael A Conlon; Anthony R Bird; Michael J Adams; David L Topping; Mahinda Y Abeywardena
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

Review 5.  Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients.

Authors:  Todd T Brown; Danielle L Zelnik; Adrian S Dobs
Journal:  Int J Gastrointest Cancer       Date:  2003

6.  Prebiotic treatment reduced preneoplastic lesions through the downregulation of toll like receptor 4 in a chemo-induced carcinogenic model.

Authors:  Masanobu Fukuda; Yutaka Komiyama; Keiichi Mitsuyama; Akira Andoh; Takahiko Aoyama; Yoshiaki Matsumoto; Osamu Kanauchi
Journal:  J Clin Biochem Nutr       Date:  2011-05-14       Impact factor: 3.114

Review 7.  Aspirin and decreased colon cancer risk: challenges interpreting a large prospective trial.

Authors:  Rita Wickham
Journal:  J Adv Pract Oncol       Date:  2012-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.